Related Experiment Video
Updated: Jun 8, 2026
17:42
A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation
Published on: April 13, 2011
Islet cell transplantation for Type 1 diabetes
1Baylor All Saints Islet Cell Laboratory, Baylor Research Institute Fort Worth Campus, Fort Worth, Texas, USA. shinichm@baylorhealth.edu
Journal of Diabetes
|October 7, 2010
Summary
Islet transplantation shows promise for Type 1 diabetes, offering insulin independence for many. Challenges like donor shortage and immunosuppression side effects are being addressed with bioartificial and regenerative approaches.
Area of Science:
- Endocrinology and Metabolism
- Transplantation Immunology
- Regenerative Medicine
Background:
- Islet transplantation offers a potential cure for Type 1 diabetes, improving glycemic control and reducing hypoglycemia.
- Current success rates are limited by donor availability, islet isolation efficiency, and immunosuppression-related side effects.
Purpose of the Study:
- To review the current status and challenges of islet transplantation for Type 1 diabetes.
- To explore innovative solutions including bioartificial islets and regenerative medicine for future treatments.
Main Methods:
- Review of existing literature on islet transplantation efficacy and limitations.
- Evaluation of emerging strategies such as living donor and bioartificial islet transplantation.
- Discussion of advancements in β-cell regeneration and generation from stem cells.
Main Results:
- Islet transplantation can achieve insulin independence in approximately 70% of Type 1 diabetes patients.
- Significant hurdles remain, including donor shortage, inconsistent isolation success, and immunosuppression toxicity.
- Bioartificial islet transplantation and regenerative therapies are promising future directions.
Conclusions:
- Islet transplantation is a viable but challenging treatment for Type 1 diabetes.
- Addressing donor scarcity and immunological barriers is crucial for wider application.
- Next-generation treatments involving bioartificial and regenerative approaches hold significant potential.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...